An energetic measurement at rest and a response to increased workload are not the same endpoint. This aged-mouse study compared SS-31, NMN, and their combination. Primary report
What was reported
SS-31 and NMN affected different cardiac functional measures. Both normalized the reported phosphocreatine-to-ATP response to increased workload. Only the combined treatment significantly increased steady-state NAD(H) in the cited analysis, while dynamic metabolite responses differed across interventions. NMN was the precursor intervention tested; it was not direct NAD-plus administration. Primary report
Our appraisal: a pool size is not a flux
A larger metabolite pool does not reveal how quickly molecules move through a pathway. Likewise, a smaller workload-induced change may reflect a different starting state rather than an inability to respond. Resting values and changes from baseline should be read together.
Combination language also needs discipline. A combined arm outperforming one component on an endpoint does not automatically establish statistical synergy. The reference model for additivity and the relevant interaction comparison must be specified. Otherwise “synergy” can become a label for any favorable combination observation.
The two compounds should remain chemically distinct. Evidence about an NAD precursor cannot be assigned directly to an NAD infusion or another precursor merely because they participate in related metabolism. Exposure and conversion are part of the question.
Full review should inspect workload standardization, baseline adjustment, multiple endpoints, and the exact combination contrasts. This report is useful for understanding complementary experimental effects in aged mouse hearts. It does not establish a human combination regimen, general longevity benefit, or superiority of a commercial blend.
Frequently asked questions
Were single and combined interventions examined?
Yes.
Is resting NAD(H) the same as metabolic flux?
No.
Was NMN the same intervention as direct NAD-plus?
No.
Did every treatment give identical dynamic responses?
No.
Does a favorable combination automatically prove synergy?
No.
Was human longevity tested?
No.
What should be retained in the interpretation?
Starting values, workload changes, compound identity, and the specified treatment contrast.